Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-23-018528

Options or other derivatives

  • Chief Science Officer acquired 205,938 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
PICKER DONALD H Chief Science Officer 2023-06-22 Grant or award · Stock option (right to buy) +100,000 332,010 D
PICKER DONALD H Chief Science Officer 2023-06-22 Grant or award · Restricted Stock Units +105,938 437,948 D
Loading xslF345X04/rdgdoc.xml…